Risk adapted regulation of clinical trials
Research Ethics 10 (1):2-5 (2014)
Abstract
This article has no associated abstract. (fix it)Author's Profile
DOI
10.1177/1747016114524520
My notes
Similar books and articles
Prudent Precaution in Clinical Trials of Nanomedicines.Gary E. Marchant & Rachel A. Lindor - 2012 - Journal of Law, Medicine and Ethics 40 (4):831-840.
Are Phase 1 Trials Therapeutic? Risk, Ethics, and Division of Labor.James A. Anderson & Jonathan Kimmelman - 2014 - Bioethics 28 (3):138-146.
A call to restructure the drug development process: Government over-regulation and non-innovative late stage (phase III) clinical trials are major obstacles to advances in health care.Thomas C. Jones - 2005 - Science and Engineering Ethics 11 (4):575-587.
Disputing the ethics of research: The challenge from bioethics and patient activism to the interpretation of the declaration of helsinki in clinical trials.Simon Woods & Pauline Mccormack - 2013 - Bioethics 27 (5):243-250.
The Duty to Disclose Adverse Clinical Trial Results.S. Matthew Liao, Mark Sheehan & Steve Clarke - 2009 - American Journal of Bioethics 9 (8):24-32.
A European consistency for functioning of RECs? We just lost our chance.Marcin Waligora - 2013 - Journal of Medical Ethics 39 (6):408-409.
Uncertainty and the ethics of clinical trials.Sven Ove Hansson - 2006 - Theoretical Medicine and Bioethics 27 (2):149-167.
Restricted treatments, inducements, and research participation.Sarah J. L. Edwards - 2006 - Bioethics 20 (2):77–91.
Valuing risk: The ethical review of clinical trial safety.Jonathan Kimmelman - 2004 - Kennedy Institute of Ethics Journal 14 (4):369-393.
Hidden risks associated with clinical trials in developing countries.C. Lorenzo, V. Garrafa, J. H. Solbakk & S. Vidal - 2010 - Journal of Medical Ethics 36 (2):111-115.
A developing country response to Lavery et al. "In global health research, is it legitimate to stop clinical trials early on account of their opportunity costs?".Douglas R. Wassenaar & Gita Ramjee - 2009 - BMC Medical Ethics 10 (1):16-.
Retractions in the medical literature: how can patients be protected from risk?R. Grant Steen - 2012 - Journal of Medical Ethics 38 (4):228-232.
The Research Misconception.Maurie Markman - 2004 - International Journal of Applied Philosophy 18 (2):241-252.
The science and ethics of placebo in pediatric psychopharmacology.Lawrence Scahill, Mary Solanto & Joseph McGuire - 2008 - Ethics and Behavior 18 (2-3):266 – 285.
Analytics
Added to PP
2014-03-14
Downloads
5 (#1,169,168)
6 months
1 (#448,894)
2014-03-14
Downloads
5 (#1,169,168)
6 months
1 (#448,894)
Historical graph of downloads
